Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vadim Backman
Northwestern University at Chicago, Department: Public Health & Prev Medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Nanocytomics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research is related to the focus of an entity in which Professor Backman has significant financial interests, NanoCytomics. NanoCytomics has licensed intellectual property arising from Northwestern research related to a technology platform within the field of nanocytology that is intended to identify patients that are likely to benefit from gold-standard cancer diagnostic procedures. Partial wave spectroscopic (PWS) microscopy is a breakthrough technology platform that enables quantification of the nanoscale architecture of the cell with unprecedented accuracy. This research features implementation of Backman's PWS technology in the early detection of pancreatic cancer. This work relates to intellectual property owned by NanoCytomics and new intellectual property arising from this research will likely utilize NanoCytomics as a commercial vehicle. Therefore, a potential conflict of interest exists regarding Professor Backman’s NanoCytomics interests and this research that should be managed.
Detection of 5-hmC as a Novel Screening Biomarker for Pancreatic Cancer
This works seeks to understand how covalent cytosine modifications (5-methylcytosines and/or 5-hydroxymethylcytosines) implicate in pancreatic cancer. Through an understanding of this epigenetic control, we may be able to utilize cytosine modifications as biomarkers for the prevention, diagnosis and prognosis of pancreatic cancer. This approach may also be applied to other human cancers.
Filed on June 08, 2016.
Tell us what you know about Vadim Backman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Vadim Backman”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Vadim Backman | Northwestern University | Conflict of Interest | NanoCytomics, LLC | Value cannot be readily determined |
| Vadim Backman | Northwestern University | Conflict of Interest | American BioOptics | Value cannot be readily determined |
| Vadim Backman | Northwestern University | Conflict of Interest | NanoCytomics | $100,000 - $149,999 |
| Vadim Backman | Northwestern University | Conflict of Interest | Nanocytomics, LLC | Value cannot be readily determined |
| Vadim Backman | Northwestern University | Conflict of Interest | NanoCytomics, LLC | $150,000 - $199,999 |
| Vadim Backman | Northwestern University at Chicago | Conflict of Interest | Nanocytomics, LLC | $150,000 - $199,999 |
| Vadim Backman | Northwestern University | Conflict of Interest | Nanocytomics | $80,000 - $99,999 |
| Vadim Backman | Northwestern University | Conflict of Interest | NanoCytomics | Value cannot be readily determined |
| Vadim Backman | Northwestern University | Conflict of Interest | Nanocytomics | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.